Back to Search
Start Over
High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.
- Source :
-
Blood [Blood] 1993 Nov 15; Vol. 82 (10), pp. 3133-40. - Publication Year :
- 1993
-
Abstract
- Mitoxantrone has been shown in vitro to exhibit a steep dose-response relationship with respect to the clonogenic survival of acute myeloid leukemia cells. In this report, we show that 1-hour exposure of human myeloid leukemia HL-60 and KG-1 cells to mitoxantrone concentrations ranging between 0.1 and 10.0 mumol/L induced internucleosomal DNA fragmentation of approximately 200-bp integer multiples, characteristic of cells undergoing programmed cell death (PCD) or apoptosis. Mitoxantrone-mediated PCD was associated with a steep inhibition of the clonogenic survival of the leukemic cells. In addition, intracellularly, mitoxantrone-induced PCD was associated with a marked induction of c-jun and significant repression of c-myc and BCL-2 oncogenes. Pretreatment with the protein kinase C stimulator phorbol myristate acetate enhanced mitoxantrone-induced internucleosomal DNA fragmentation, whereas protein kinase C inhibitors staurosporine and H7 had no effect. These findings suggest that PCD is a potential mechanism underlying the steep dose-response relationship of mitoxantrone to the inhibition of clonogenic survival of acute myeloid leukemia cells.
- Subjects :
- Cytarabine pharmacology
DNA metabolism
Dose-Response Relationship, Drug
Genes, jun
Genes, myc
Humans
Leukemia, Myeloid genetics
Proto-Oncogene Proteins genetics
Proto-Oncogene Proteins c-bcl-2
Tetradecanoylphorbol Acetate pharmacology
Tumor Cells, Cultured
Apoptosis drug effects
Leukemia, Myeloid pathology
Mitoxantrone pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 82
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 8219202